Ubs Oconnor LLC Axogen, Inc. Transaction History
Ubs Oconnor LLC
- $1.44 Billion
- Q1 2025
A detailed history of Ubs Oconnor LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 87,428 shares of AXGN stock, worth $958,210. This represents 0.11% of its overall portfolio holdings.
Number of Shares
87,428Holding current value
$958,210% of portfolio
0.11%Shares
11 transactions
Others Institutions Holding AXGN
# of Institutions
191Shares Held
39.2MCall Options Held
61.7KPut Options Held
42.8K-
First Light Asset Management, LLC Edina, MN4.47MShares$49 Million10.62% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$35.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.6MShares$28.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$27.8 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.59MShares$17.4 Million0.54% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $463M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...